Plexium Announces $102M Financing To Advance Pipeline Of Targeted Protein Degradation Therapies And Technology Platform
Amount Raised
$102 Million
Round Type
Funding Round
San DiegoBiotechnologyHealth CareDescription
Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced the completion of an oversubscribed $102M financing, led by BVF Partners, L.P. and TCG X, with participation from new investors Softbank Vision Fund 2, RA Capital Management, Surveyor Capital (a Citadel company), and Pappas Capital. Existing investors The Column Group, DCVC Bio, Pivotal bioVenture Partners, Lux Capital, M Ventures, CRV and Neotribe Ventures also participated in the round
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Plexium that raised within 45 days of this round, from Fundz verified event records.
- Promaxo raised an undisclosed amount (Funding Round) on April 7, 2022.
- Trait Biosciences Inc. raised $210K (Series A) on April 6, 2022.
- Ensem Therapeutics raised $67M (Series A) on April 6, 2022.
- Autonomix Medical raised $2M (Seed) on April 6, 2022.
- BostonGene raised $150M (Series B) on April 6, 2022.
- Alto Neuroscience raised $59M on April 6, 2022.
Who to call at Plexium, and when
A new round usually means Plexium is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Plexium raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Plexium, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Plexium. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Plexium raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Plexium raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.